Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IGM Biosciences
Biotech
IGM, Y-mAbs, Passage Bio and more ring in 2025 with layoffs
IGM, Y-mAbs, Passage Bio and Shoreline Biosciences have each revealed plans to cut jobs as they rework their pipelines and business structures.
Fraiser Kansteiner
Jan 10, 2025 2:44pm
Prothena promotes one exec while another leaves—Chutes & Ladders
Oct 4, 2024 8:00am
IGM pivots from cancer to autoimmune, shaking up C-suite
Oct 1, 2024 7:05am
Sanofi shrinks $6B biobucks deal with IGM
Apr 17, 2024 11:05am
IGM cuts head count 22%, stops blood cancer work to stretch cash
Dec 6, 2023 10:11am
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront
Mar 29, 2022 7:20am
